SCHEMBL4697729

SCHEMBL4697729

COc1ccc(N2CCN(C)CC2)cc1CC#N

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 3/20 0.49
SIRT6 Q8N6T7 1/20 0.48
POLB P06746 2/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
HTR7 P34969 1/20 0.43
TNIK Q9UKE5 2/20 0.42
NSD2 O96028 1/20 0.42
CTSB P07858 1/20 0.41
CTSS P25774 1/20 0.41
CTSK P43235 1/20 0.41
DRD2 P14416 2/20 0.41
DRD3 P35462 2/20 0.41
HTR3A P46098 1/20 0.41
DRD4 P21917 1/20 0.41
HRH2 P25021 1/20 0.41
HRH3 Q9Y5N1 1/20 0.41
KDM4E B2RXH2 2/20 0.40
GAA P10253 2/20 0.40
MAPT P10636 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7916967 0.87 SLC16A3 (0.50) NPC1RAB9AHTR7CTSBCTSS
SCHEMBL7920291 0.83 HTR7 (0.38) HTR6SIRT6HTR7CTSBCTSS
SCHEMBL13243994 0.77 SIRT6 (0.63) HTR6SIRT6POLBNPC1RAB9A
SCHEMBL4177871 0.75 SIRT6 (0.48) HTR6SIRT6POLBNPC1RAB9A
SCHEMBL1911838 0.74 SIRT6 (0.56) HTR6SIRT6POLBNPC1RAB9A
SCHEMBL21566486 0.74 SIRT6 (0.59) HTR6SIRT6POLBNPC1RAB9A
SCHEMBL13225331 0.74 HTR6 (0.64) HTR6SIRT6POLBNPC1RAB9A
SCHEMBL1527171 0.73 MAPT (0.58) HTR6SIRT6POLBNPC1RAB9A
SCHEMBL30595859 0.73 MAPT (0.58) HTR6SIRT6POLBNPC1RAB9A
SCHEMBL1599288 0.73 FYN (0.57) HTR6SIRT6POLBNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1993552-A2 USE OF PYRAZOLO[1,5A]PYRIMIDIN-7-YL AMINE DERIVATIVES IN THE TREATMENT OF NEUROLOGICAL DISORDERS Novartis AG (CH) 2008-11-26 EP disclosed
WO-2007103432-A9 USE OF PYRAZOLO[1,5A]PYRIMIDIN-7-YL AMINE DERIVATIVES IN THE TREATMENT OF NEUROLOGICAL DISORDERS NOVARTIS AG (CH) 2008-01-10 WO disclosed
WO-2007103432-A2 USE OF PYRAZOLO[1,5A]PYRIMIDIN-7-YL AMINE DERIVATIVES IN THE TREATMENT OF NEUROLOGICAL DISORDERS NOVARTIS AG (CH) 2007-09-13 WO disclosed